期刊文献+

脑血管病神经保护治疗的现状、趋势及存在问题 被引量:7

Current status of neuroprotection in cerebrovascular disease
下载PDF
导出
摘要 对近年最新的有关脑血管病神经保护治疗的研究进行综述。目前神经保护治疗的主要类型 ,包括离子通道调节药、抗兴奋毒性作用、自由基清除剂、神经营养因子、低温处理以及基因治疗和神经干细胞治疗等。不同治疗的目的大多是通过阻止缺血分子瀑的一个或多个环节的发展来减轻脑缺血损伤。多数神经保护药的临床疗效尚未被证实 ,有些制剂因其不良反应大而被弃用。由于神经保护治疗有着很广的适应证 ,因而引起人们的广泛重视。目前至少有 6个神经保护药正在进行Ⅲ期临床试验 。 The role of neuroprotection in the treatment of acute cerebrovascular disease is reviewed. Various neuroprotective strategies include ion channel modulators,anti excitotoxic agents,free radical scavengers,neurrotrophic factors,hypothermia,gene therapy and stem cells. The various agents aim to prevent the progression of ischemic cascade therefore reducing brain injury through more than one point in the ischemic cascade. Clinical effectiveness of most of the strategies has not been proven in clinical trials. Some of which had to be abandoned due to adverse effects outweighing the beneficial effects. At least six neuroprotective agents based on various mechanisms are in phase Ⅲ of clinical trials. The most promising appear to be free radical scavengers and anti excitotoxic agents.
作者 刘新峰
出处 《医学研究生学报》 CAS 2003年第6期452-455,共4页 Journal of Medical Postgraduates
关键词 神经保护 脑缺血 血-脑屏障 Neuroprotection Cerebral ischemia Blood brain barrier
  • 相关文献

参考文献20

  • 1Goldberg MP. Stroke Trials Database,Internet Stroke Center at Washington University. (http://www.neuro.wustl.edu/stroke).
  • 2Lee JM,Zipfel GJ,Choi DW. The changing landscape of ischemic brain injury mechanisms[J].Nature,1999,399(Suppl):A7-A14.
  • 3Jain KK. Neuroprotection in cerebrovascular disease[J].Exp Opin Invest Drugs,2000,9(4):695-711.
  • 4Kato H,Kogure K. Biochemical and molecular characteristics of the brain with developing cerebral infarction[J].Cell Mol Neurobiol,1999,19:93-108.
  • 5Dunlop J,Zaleska M,Eliadof S et al.Excitatory amino acid transporters as emerging targets for central nervous system therapeutics[J].Emerging Ther Targets,1999,3:543-570.
  • 6Yamaguchi T,Sano K,Takakura K et al.For the Ebselen Study Group. Ebselen in acute ischemic stroke: a placebo-controlled,double-blind clinical trail[J].Stroke,1998,29:12-17.
  • 7Saito I,Asano T,Sano K et al. Neuroprotective effect of an antioxidant,ebselen,in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage[J].Neurosurgery,1998,42:269-278.
  • 8Semkova I,Krieglstein J. Neuroprotection mediated via neurotrophic factors and induction of neurotrophic factors[J].Brain Research Reviews,1999,30:176-188.
  • 9Tamatani M,Ogawa S,Nunez G et al.Growth factors prevent changes in Bcl-2 and Bax expression and neuronal apoptosis induced by nitric oxide[J].Cell Death and Differentiation,1998,5: 911-919.
  • 10Liu XF,Fawcett JR,Thorne RG et al. Intranasal administration of insulin-like growth factor-I bypasses the blood-brain barrier and protects against focal cerebral ischemic damage[J].J Neurol Sci,2001,187:91-97.

同被引文献85

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部